Skip to content

Longitudinal cohort paired study of peripheral blood biomarkers for Alzheimer's disease

Longitudinal cohort paired study of peripheral blood biomarkers for Alzheimer's disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047000
Enrollment
Unknown
Registered
2021-06-06
Start date
2021-06-07
Completion date
Unknown
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Alzheimer's disease Group-mild:No intervention
Alzheimer's disease-moderate:No intervention

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Alzheimers disease entry criteria: meet the National Institute on Aging–Alzheimers Association (NIA-AA): (1) The chief complaint of memory loss, which was confirmed by an insider; (2) Based on clinical examination, the diagnosis of dementia can be made and verified by cognitive scale test (20 items ADL>26 points; CDI>1 point); (3) Unconscious disorder; (4) All cases undergo MRI examination and related laboratory examinations, except for other diseases that can cause progressive impairment of memory and cognitive function; (5) Amyloid/p-Tau increased in PET tracing or Aß1-42 in cerebrospinal fluid increased with/or P-Tau increased. 2. Entry criteria for mild cognitive impairment: (1) The main complaint was memory loss, which was confirmed by an insider; (2) Objective inspection revealed mild cognitive impairment that was not commensurate with age and education level; (3) The overall cognitive function is normal, the basic ability of daily life is normal, and complicated daily or social functions may be slightly impaired; (4) No dementia (CDR0.5 points, 20 items ADL 27/30 points and normal neuropsychological evaluation; (2) Clinical Dementia Score (CDR) score = 0; (3) No history of neurological or mental illness; (4) No memory complaints or cognitive deficits.

Exclusion criteria

Exclusion criteria: 1. Sudden onset; 2. Early general situational memory impairment; 3. Cognitive disorders caused by depression, cerebrovascular, moderate, inflammation or metabolic disorders.

Design outcomes

Primary

MeasureTime frame
Blood early biomarkers for Alzheimer's disease;skull PET/CT(MR);Assessment of cognitive function;

Countries

China

Contacts

Public ContactPeng Dantao

China-Japan Friendship Hospital

13910908579@163.com+86 13910908579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026